|  | 1 month after treatment | 2 months after treatment |
---|---|---|---|
Treatment groups | responders at week 4 | remaining responders/ evaluated responders†| remaining responders/ evaluated responders†|
Placebo | 13 | 11/12 | 9/12 |
Diclofenac | 18 | 10/16 | 7/15 |
EA | 27 | 21/25 | 19/24 |
Combined | 24 | 14/24 | 14/24 |
p value** | Â | 0.12 | 0.19 |